Switzerland is traditionally strong in this sector and enjoys a high reputation world-wide. The Product Pipeline gives an overview on indications and therapeutic areas of interest for our member companies.

Our communities members find relevant information on developments, news and events within the different community platforms::

• Clinical develoment and regulatory issues
• Therapeutic biologics and advanced therapies
• Rare diseases and orphan medicinal products